Immune Response BioPharma Inc - Product Pipeline Review - 2016

Published: Dec, 2016 | Pages: 42 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Immune Response BioPharma Inc - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Immune Response BioPharma Inc - Product Pipeline Review - 2016', provides an overview of the Immune Response BioPharma Inc's pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Immune Response BioPharma Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Immune Response BioPharma Inc
- The report provides overview of Immune Response BioPharma Inc including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Immune Response BioPharma Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Immune Response BioPharma Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Immune Response BioPharma Inc's strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Immune Response BioPharma Inc
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Immune Response BioPharma Inc's pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

 Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Immune Response BioPharma Inc Snapshot 6
Immune Response BioPharma Inc Overview 6
Key Facts 6
Immune Response BioPharma Inc - Research and Development Overview 7
Key Therapeutic Areas 7
Immune Response BioPharma Inc - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Immune Response BioPharma Inc - Pipeline Products Glance 11
Immune Response BioPharma Inc - Late Stage Pipeline Products 11
Pre-Registration Products/Combination Treatment Modalities 11
Immune Response BioPharma Inc - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Immune Response BioPharma Inc - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Immune Response BioPharma Inc - Drug Profiles 15
IR-007 - Drug Profile 15
Product Description 15
Mechanism Of Action 15
R&D Progress 15
IR-1000 - Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
IR-1002 - Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
IR-103 - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
IR-2020 - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
IR-222 - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
IR-444 - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
IR-502 - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
IR-555 - Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
IR-777 - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
IR-888 - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
IR-902 - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
IR-999 - Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
IRE-101 - Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
IRR-102 - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
IRS-103 - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
Remune - Drug Profile 33
Product Description 33
Mechanism Of Action 33
R&D Progress 33
Immune Response BioPharma Inc - Pipeline Analysis 36
Immune Response BioPharma Inc - Pipeline Products by Target 36
Immune Response BioPharma Inc - Pipeline Products by Route of Administration 37
Immune Response BioPharma Inc - Pipeline Products by Molecule Type 38
Immune Response BioPharma Inc - Dormant Projects 39
Immune Response BioPharma Inc - Locations And Subsidiaries 40
Head Office 40
Appendix 41
Methodology 41
Coverage 41
Secondary Research 41
Primary Research 41
Expert Panel Validation 41
Contact Us 41
Disclaimer 42

List of Tables

Immune Response BioPharma Inc, Key Facts 6
Immune Response BioPharma Inc - Pipeline by Indication, 2016 8
Immune Response BioPharma Inc - Pipeline by Stage of Development, 2016 9
Immune Response BioPharma Inc - Monotherapy Products in Pipeline, 2016 10
Immune Response BioPharma Inc - Pre-Registration, 2016 11
Immune Response BioPharma Inc - Phase II, 2016 12
Immune Response BioPharma Inc - Phase I, 2016 13
Immune Response BioPharma Inc - Preclinical, 2016 14
Immune Response BioPharma Inc - Pipeline by Target, 2016 36
Immune Response BioPharma Inc - Pipeline by Route of Administration, 2016 37
Immune Response BioPharma Inc - Pipeline by Molecule Type, 2016 38
Immune Response BioPharma Inc - Dormant Developmental Projects,2016 39